Personalized Disease Management
We understand that every patient is unique and individualized treatment is often necessary. We strive to help physicians improve patient outcome through personalized therapy. Our passion is slowing and ultimately preventing the progression of autoimmune diseases and its associated disabilities.

To address this need, Glycominds offers diagnostic and prognostic tests that give physicians additional information to guide treatment decisions for patients with Multiple Sclerosis and Crohn's Disease.
News & Events
CLIA Certified
Glycominds Inc. Laboratory in Simi Valley, CA has been CLIA certified




ECTRIMS 2010
We will be attending the ECTRIMS in Oct 13-16.2010 in Sweden
We will be presenting 2 new posters regarding our gMS tests


CLIA Certified
CLIA: Glycominds Inc., USA gMS laboratories has been CLIA certified


Blood tests for Multiple Sclerosis
www.gms.net
IVD kits for individualized risk assessment of complicated Crohn's Disease patients
www.ibdx.net
site map | Privacy Policy | contact us
© 2010 Glycominds Ltd. All Right Reserved